Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by wagyusteakon Dec 31, 2020 2:19pm
146 Views
Post# 32204684

RE:RE:RE:RE:RE:RE:How was this resolved?

RE:RE:RE:RE:RE:RE:How was this resolved?
Spirou25 wrote:
Michel1234 wrote:

Concerning the tax litigation.

The year-end financial statements are audited by a big accounting firm. Until the amount paid to the tax authorities stay recorded as an account receivable, it should generally mean that the auditor accept the management position that it is more likely than not that Knight will eventually get a refund once the litigation is over. 

Michel



Reality in sometimes different than that unfortunately. If you are/have been an auditor yourself I am pretty sure you know what I am refering to.


The money is gone, so it's not gonna affect out cash flow in the future if we cannot get the refund. On the other hand, it will be a huge plus if we get that money back. So the risk is none while the upside is big.
<< Previous
Bullboard Posts
Next >>